3-MEO-PCP
3-MEO-PCP €111.15
Til baka í vörur
Staðgengill
Klónazólam 0,6 mg kúlur €0.00
5-EAPB - Mynd 1
5-EAPB - Mynd 2

5-EAPB

5-EAPB properties

Samheiti 1-(bensófúran-5-ýl)-N-etýlprópan-2-amín, mónóhýdróklóríð
CAS-númer : 1445560-01-7
Formúla C13H17NO • HCl
Mólmassi : 239,8 g/mól
Hreinleiki : ≥99%

Verðbil: €15.00 til €200.00

Bæta við til að bera saman
Bæta við óskalista
SPARAÐU 15%

fleiri 2 vörur

SPARA 50%

6 á verði 3

* Upplýsingarnar á þessari síðu eru samantekt og eru ekki ætlaðar til að ná yfir allar tiltækar upplýsingar um þetta lyf. Þær fjalla ekki um alla mögulega notkun, leiðbeiningar, varúðarráðstafanir, milliverkanir lyfja eða aukaverkanir og koma ekki í stað sérfræðiþekkingar og mats heilbrigðisstarfsmanns.

5-EAPB (5-(2-Aminopropyl)benzofuran) – Benzofuran Research Substance with Monoaminergic Activity

What is 5-EAPB?

5-EAPB (5-(2-Aminopropyl)benzofuran) is a synthetic benzofuran derivative that shares structural features with both phenethylamines and amphetamines. This compound is being studied in the field of neurotransmitter modulation and receptor activity and is intended for laboratory use only. 1V-LSD 150 MCG þynnur

Lykilatriði

  • Purity ≥98% (checked by GC-MS, HPLC, NMR)
  • Crystalline consistency, suitable for precise laboratory application
  • Packed with oxygen and moisture resistant technology
  • Complete batch-specific documentation

Lyfjafræðilegt efni

  • Dopamine reuptake inhibition: high
  • Serotonin reuptake inhibition: average
  • Noradrenaline reuptake inhibition: slight

Lyfjahvörf

  • Rise: 30–60 minutes
  • Duration of action: 4–6 hours
  • Half-life: approx. 8 hours (preclinical models)

Notkun í rannsóknum

  1. Taugaefnafræðilegar rannsóknir
    • Receptor binding (monoaminergic)
    • Synaptic release processes
    • Transporter effectiveness
  2. SAR rannsóknir
    • Benzofuran vs. phenethylamine comparison
    • Substitution pattern and activity
  3. Behavioral research

Tæknilegar upplýsingar

  • Molecular formula: C11H13NO
  • Molecular weight: 175.23 g/mol
  • Appearance: White to light yellow crystalline powder
  • Melting point: 162–165°C
  • Leysni: >50 mg/ml í etanóli

Analytical Data

  • HPLC retention time: 8.1 ± 0.3 min
  • MS peak: m/z 176 [M+H]+
  • 1H NMR (CDCl₃): δ 7,5–7,7 (m, 3H), 6,8 (d, 1H), 3,2 (m, 1H)

Research dosage (Reference)

  • Í tilraunaglasi: 1–100 µM
  • In vivo (preclinical): 0.5–3.0 mg/kg
  • Chemical analysis: 5–25 mg per sample

Öryggi og geymsla

  • Shelf life: 36 months at -20°C
  • Storage conditions: Inert gas, airtight container
  • Compatible with common buffers (PBS, ethanol)
  • Processing under a fume hood is recommended

Skjölun við afhendingu

  • Certificate of Analysis (HPLC, MS, NMR)
  • Öryggisblað (SDS)
  • Technical datasheet with solution protocols
  • Spectral references (¹H NMR, ¹³C NMR, FTIR, MS)

For scientific research only. Not suitable for consumption or medical use. 1cP-LSD 150 MCG listabletti